This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
EU Pharmaceutical Law Forum 2024
May 21-23, 2024Steigenberger Wiltcher's, Brussels
EU Pharmaceutical Law Forum 2024
May 21-23, 2024,
Steigenberger Wiltcher's, Brussels

Join Dechert at EU Pharmaceutical Law Forum 2024

You're Invited to EU Pharma Law with an Exclusive 10% Off

We are excited to announce that Dechert will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Dechert, we have an exclusive 10% discount* for you. Your VIP discount code is: P24DECHERT

*T&C's Apply

TRI DIALOGUE Regulatory Framework Developments for Artificial Intelligence

  • How does the EU MDR and IVDR fit with the AI Act?
  • Practical considerations for pharmaceutical companies and device manufacturers
  • Update on EMA reflection paper on use of AI in medicinal product lifecycle
  • Overlaying European proposals with US frameworks for AI and the implications for global policies

DUAL DIALOGUE Advice on Key Antitrust Hurdles Impacting Commercial Transactions

  • Foreign subsidies regulation: what are the obligations?
  • Review of recent pharmaceutical merger control cases and authority approach
  • Horizontal Block Exemption Regulations and revised Horizontal Guidelines
  • Given today’s environment how can you prepare for regulatory scrutiny in commercial transactions?

Opening Remarks from Morning Chair

  • Recent developments and global antitrust trends
  • Influence of EU antitrust thinking on US approach